What Breast Implant Clinical Trials Actually Are and Why They Matter
A clinical trial for breast implants is a structured research study where people volunteer to test new implant designs, materials, or surgical techniques before they become widely available to the general public. These trials exist because the Food and Drug Administration (FDA) requires manufacturers to prove that medical devices—including breast implants—are safe and work as intended before approval. Unlike medication trials that test how a drug affects your body chemistry, breast implant trials focus on how the implants perform over time: Do they hold their shape? Do they rupture? How do they feel? What complications arise, if any?
Find and View Your Saved Passwords on Windows →
The breast implant trial landscape has shifted significantly over the past 30 years. In the 1990s and early 2000s, silicone breast implants were essentially unavailable in the United States due to safety concerns, though this ban was lifted in 2006. Today, most new clinical trials involve refinements to existing implant technology—newer silicone formulations, textured surfaces designed to reduce capsular contracture (scar tissue buildup), or innovative shapes meant to look more natural. Some trials also test regenerative approaches or fat transfer techniques as alternatives to traditional implants.
Participation in these trials is different from getting breast augmentation surgery through a private plastic surgeon. Trial participants are part of a research protocol with specific requirements: regular follow-up appointments (sometimes for 10 years or longer), imaging studies like mammograms or ultrasounds, standardized questionnaires about satisfaction and complications, and detailed documentation of any adverse events. The manufacturer and often an independent data safety monitoring board oversee the results.
Why should you know this? Understanding how clinical trials work helps you make informed decisions if you're considering breast augmentation. You may encounter trial opportunities through your surgeon's office, hospital system, or direct recruitment from device manufacturers. Knowing the difference between a trial and standard surgery—including the added monitoring and paperwork—prevents surprises down the road.
Practical takeaway: Clinical trials are research projects, not just surgeries. They require longer-term commitment and more follow-up appointments than standard procedures, but they also provide access to newer technologies and contribute to medical knowledge about implant safety.
How the FDA Review Process Works for Breast Implant Devices
Before a new breast implant design reaches clinical trial stages, it goes through what the FDA calls the "pre-clinical phase"—laboratory and animal testing to show basic safety. Once that data looks promising, manufacturers can request an Investigational Device Exemption (IDE), which permission to conduct human trials. The FDA reviews the IDE application, the trial protocol, and the manufacturing details to determine whether the proposed study can safely proceed.
Get Your Free New Jersey Property Tax Rebate Guide →
During the clinical trial itself, data accumulates from all participants. For breast implants specifically, the FDA typically wants to see information about rupture rates, infection rates, capsular contracture (the formation of scar tissue), and patient satisfaction. Most breast implant trials track outcomes for at least 10 years, though some studies continue for decades. Researchers document everything: surgical complications, implant longevity, revision surgeries, and any systemic complaints participants report.
Once the clinical trial data is complete, the manufacturer submits a Premarket Approval (PMA) application to the FDA. This document summarizes all the trial results, explains how the implant is manufactured, describes labeling and instructions, and argues why the implant is safe and effective. The FDA's Center for Devices and Radiological Health reviews the PMA, which can take several months to over a year. FDA reviewers may request additional information, and the manufacturer must respond. Eventually, the FDA issues either an approval letter (allowing the device to be marketed) or a denial (requiring redesign and resubmission).
Even after approval, the FDA continues monitoring through a system called post-market surveillance. Manufacturers must track implant complications reported by surgeons and patients. The FDA can require additional studies if safety concerns emerge after approval. For breast implants specifically, the FDA has held several advisory committee meetings in recent years to review long-term safety data and discuss whether additional monitoring should continue indefinitely.
Practical takeaway: The FDA process takes years and involves multiple checkpoints before and after approval. If you're considering a "new" implant, it may have been in trials for 5-10 years already. Understanding this timeline helps you recognize why implants available through trials are still investigational and not yet available to all surgeons.
Types of Breast Implant Trials Currently Happening and What They Test
Silicone gel breast implant trials dominate the current landscape. Modern trials often focus on newer silicone formulations designed to be more cohesive (thicker and less likely to leak if ruptured) or textured surfaces meant to reduce the risk of capsular contracture—a painful condition where scar tissue tightens around the implant. Manufacturers like Mentor, Allergan, and Natrelle conduct ongoing trials for refined versions of existing implant lines. These trials recruit women seeking breast augmentation, breast reconstruction after mastectomy, or revision surgeries to replace old implants.
Free Guide to Unlocking a Disabled iPhone →
Implant shape variations represent another trial category. Traditional round implants provide fullness across the entire breast. Anatomical or "teardrop" shaped implants aim to create a more natural slope and projection. Some trials test high-profile implants (more projection forward) versus moderate-profile (less projection, more spread). Participants in shape-comparison trials may undergo imaging and questionnaires asking whether they perceive a visual difference and whether they're satisfied with the final appearance.
Surface texture trials are particularly active. Smooth implants were the standard for decades, but textured implants gained popularity because preliminary data suggested they reduced capsular contracture. However, textured implants became controversial after a link was identified between certain textured implants and a rare type of lymphoma (called BIA-ALCL). Current trials are testing new surface technologies—some textured, some with novel patterns—to find the best balance between aesthetic outcomes and safety. These trials include more rigorous monitoring with MRI scans and blood work.
Some trials test implant placement techniques. Sub-muscular placement (under the chest muscle) versus sub-glandular placement (under breast tissue but over muscle) can affect how natural the implant feels and looks, especially over time. A few trials are comparing these placements directly to measure differences in complications and patient satisfaction. Other emerging trials explore fat transfer or stem cell approaches as adjuncts to implants or as standalone alternatives, though these remain less common in the United States.
Practical takeaway: Most active trials refine proven technologies (silicone implants) rather than introduce completely new ones. If you're offered a trial, ask specifically what's being tested—a new implant material, a new shape, a new surface texture, or a new surgical approach. The answer tells you how "new" the technology actually is.
The Real Commitment: What Participation Actually Involves
Enrolling in a breast implant clinical trial means committing to a long-term relationship with the research team. The typical trial protocol requires baseline visits (initial assessment and surgery), followed by follow-up appointments at 6 weeks, 3 months, 6 months, 1 year, and then annually for 10 years or longer. Some trials ask for interim assessments at additional time points. Each visit typically includes a clinical examination by the surgeon or research coordinator, completion of standardized questionnaires about pain, satisfaction, and quality of life, and possibly imaging studies like ultrasound or MRI.
Learn About Medicare Recliner Lift Chair Coverage Options →
Imaging commitments can be substantial. Many trials include mammography screening as part of long-term safety monitoring, especially if participants reach an age where mammography is routinely performed. Some trials also require MRI scans at specific intervals—for example, at 2 years and 10 years—to check for implant integrity. If you have metal implants or claustrophobia, MRI requirements may affect your willingness to participate. Discuss these details before enrolling.
Paperwork and questionnaires are constant. Participants complete standardized forms assessing breast satisfaction on a scale (often called the BREAST-Q), record any symptoms they experience (pain, swelling, changes in sensation), and note any medical visits or procedures related to the breasts. Some trials ask participants to report complications or concerns via an online portal or phone call. Others rely on mailed forms. The burden isn't extreme, but it requires organization and follow-through.
Travel and time flexibility matter more than many people realize. If your